Lindbrook Capital’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.72K | Sell |
102
-31
| -23% | -$524 | ﹤0.01% | 2322 |
|
|
2024
Q4 | $2.46K | Sell |
133
-139
| -51% | -$2.57K | ﹤0.01% | 2247 |
|
|
2024
Q3 | $5.91K | Sell |
272
-75
| -22% | -$1.63K | ﹤0.01% | 1944 |
|
|
2024
Q2 | $6.81K | Buy |
347
+234
| +207% | +$4.59K | ﹤0.01% | 1843 |
|
|
2024
Q1 | $2.45K | Buy |
113
+60
| +113% | +$1.3K | ﹤0.01% | 2168 |
|
|
2023
Q4 | $1.53K | Buy |
+53
| New | +$1.53K | ﹤0.01% | 2358 |
|
|
2023
Q3 | – | Sell |
-8
| Closed | -$296 | – | 2742 |
|
|
2023
Q2 | $296 | Sell |
8
-29
| -78% | -$1.07K | ﹤0.01% | 2617 |
|
|
2023
Q1 | $1.16K | Sell |
37
-218
| -85% | -$6.81K | ﹤0.01% | 2426 |
|
|
2022
Q4 | $7.59K | Sell |
255
-160
| -39% | -$4.77K | ﹤0.01% | 1572 |
|
|
2022
Q3 | $16K | Buy |
415
+134
| +48% | +$5.17K | ﹤0.01% | 1097 |
|
|
2022
Q2 | $15K | Buy |
281
+31
| +12% | +$1.66K | ﹤0.01% | 1091 |
|
|
2022
Q1 | $16K | Sell |
250
-70
| -22% | -$4.48K | ﹤0.01% | 1099 |
|
|
2021
Q4 | $32K | Sell |
320
-30
| -9% | -$3K | ﹤0.01% | 864 |
|
|
2021
Q3 | $31K | Buy |
350
+50
| +17% | +$4.43K | 0.01% | 591 |
|
|
2021
Q2 | $28K | Hold |
300
| – | – | 0.01% | 661 |
|
|
2021
Q1 | $29K | Sell |
300
-50
| -14% | -$4.83K | 0.01% | 607 |
|
|
2020
Q4 | $18K | Buy |
350
+50
| +17% | +$2.57K | ﹤0.01% | 718 |
|
|
2020
Q3 | $12K | Buy |
+300
| New | +$12K | ﹤0.01% | 772 |
|